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Target-dependent biogenesis of cognate
microRNAs in human cells
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Extensive research has established how miRNAs regulate target mRNAs by translation
repression and/or endonucleolytic degradation in metazoans. However, information related to
the effect of target mRNA on biogenesis and stability of corresponding miRNAs in animals is
limited. Here we report regulated biogenesis of cognate miRNAs by their target mRNAs.
Enhanced pre-miRNA processing by AGO-associated DICER1 contributes to this increased
miRNP formation. The processed miRNAs are loaded onto AGO2 to form functionally
competent miRISCs both in vivo and also in a cell-free in vitro system. Thus, we identify an
additional layer of posttranscriptional regulation that helps the cell to maintain requisite levels
of mature forms of respective miRNAs by modulating their processing in a target-dependent
manner, a process happening for miR-122 during stress reversal in human hepatic cells.
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M
icroRNAs (miRNAs) are small B21-nucleotide-long
non-coding RNAs that act as the key posttranscrip-
tional regulators of gene expression in metazoans. In
mammals, miRNAs are predicted to control the activity of460%
of all protein-coding genes and participate in the regulation of
almost every cellular process investigated to date1. Efficient
miRNA functioning requires its assembly into miRNPs where the
miRNA guide strand serves as the specificity determinant for
target RNA recognition and the effector proteins, primarily
comprising Argonaute, mediate translation repression and/or
target RNA degradation. Animal miRNAs usually hybridize with
imperfect complementarities to 30-untranslated region (UTR) of
target messenger RNAs. The 50-seed region of the small RNA is
crucial for target recognition and 30-half contributes to the
stability of the association2. The human genome codes for four
different Argonaute proteins (hAGO1–4)3,4. Of these, AGO2 is
the most abundantly expressed Argonaute protein5. AGO2 is
primarily responsible for endonulceolytic cleavage of messages
with perfect complementarity to small RNAs6.
miRNAs are endogenously transcribed from specific genes by
RNA polymerase II as capped and poly-adenylated primary
transcripts (pri-miRNAs) that are processed within the nucleus
by the Microprocessor complex (Drosha/DGCR8 in humans)
to generate 60- to 70-nt-long stem-loop precursor molecules (pre-
miRNAs)7–9. The pre-miRNAs are exported from the nucleus to
the cytoplasm via the Exportin 5 complex10–12, where the RNase
III endonuclease DICER1 processes these precursors to generate
transient double-stranded miRNA/miRNA* duplexes with 2 nt
30-overhangs13,14. The exact mechanism of miRNA Induced
Silencing Complex (miRISC) assembly has always remained
elusive. A human miRNA loading complex (miRLC) has been
described, which displays both precursor processing and RISC
cleavage activity when exposed sequentially to a miRNA
precursor and to a fully complementary target RNA15,16. Thus,
the miRLC couples the process of miRNA biogenesis with target
RNA cleavage. The miRLC comprises of DICER1, TRBP2 and
miRNA-free AGO protein as its components. Mammalian
DICER1 enzymes are large 217 kDa proteins containing
ATPase/RNA helicase, DUF283, PAZ domains, two catalytic
RNase III domains and a carboxy-terminal dsRBD17,18. The
RNaseIII domain of DICER1 interacts with PIWI domain of
AGO proteins, which is crucial for miRNA loading of AGOs19.
TRBP2, a dsRBD protein partner of DICER1, has been shown to
be required for optimal silencing of target gene20. Furthermore, it
has also been shown that once the AGO2 is loaded with the
miRNA, the miRISC dissociates from the miRLC and the loaded
miRISC can now catalyse multiple rounds of repression and
target RNA cleavage16.
More than half of the protein-coding genes in humans
contain at least one conserved miRNA binding site apart from
several other non-conserved sites17. Therefore, it is apparent that
biogenesis, function and turnover of these small RNAs need to be
effectively regulated. miRNA gene transcription, microprocessor-
mediated pri-miRNA processing, exportin-mediated export
from the nucleus to cytoplasm and cytoplasmic pre-miRNA
processing are all reported to be under stringent regulation17. The
target mRNA could itself act as a regulator of the miRNA. In
Caenorhabditis elegans, it has been observed that exoribonuclease
XRN-2-mediated degradation of miRNAs is prevented in the
presence of target mRNAs21. On the contrary, it has been
reported in Drosophila that extensive complementarities between
a target RNA and an Argonaute1-bound miRNA trigger miRNA
tailing and 30–50 trimming22.
We observe target mRNA-dependent biogenesis of mature
miR-122 from pre-miR-122 in human hepatoma cells during
recovery from amino acids starvation-related stress. This
eventually leads to the finding that the presence of abundant
amounts of mRNA bearing target sites for a particular miRNA
induces increased biogenesis of the mature miRNA from the
precursor. These miRNAs are loaded onto AGO2 to form
functionally active miRISCs. The increased production of miRNA
is proportional to the concentration of target mRNA. Using
in vitro RISC-loading assay systems, we identify that increased
processivity of AGO2-associated DICER1 in the presence of
target mRNA contributes to higher biogenesis of mature miRNA
from the pre-miRNA.
Results
Amino acid stress reversal induces miR-122 biogenesis. In the
human hepatoma cell line Huh7, expression of cationic amino
acid transporter-1 (CAT-1) is regulated by miR-122 (refs 23,24).
The 30-UTR of human CAT-1 mRNA harbours four
miR-122-binding sites. In Huh7 cells, low CAT-1 protein level
is maintained by high miR-122 activity. However, on amino
acid starvation CAT-1 mRNA is upregulated23. Besides a
transcriptional upsurge, repressed CAT-1 mRNAs are released
from RNA processing bodies or P-bodies and recruited to
polysomes leading to a translational hike25. How the excess
CAT-1 mRNAs get back to a repressed state when the starved
cells are re-exposed to amino acids has not been studied.
In an attempt to decipher the effect of stress reversal, Huh7
cells were starved for 4 h, then replenished with amino acid-
supplemented medium for additional 2 h, and changes in miRNA
and CAT-1 mRNA levels were scored (Fig. 1a). Within 4 h of
amino acid starvation, there was a threefold surge in CAT-1
mRNA (Fig. 1b). However, on re-feeding the cells with amino
acids, within 2 h CAT-1 mRNA was restored to a lower level
accompanied by an increase in mature miR-122 level (Fig. 1b,c,e).
Quantification of absolute copy numbers of miR-122 and CAT-1
mRNA per cell further confirmed the reciprocal regulation of
these two molecules during starvation and re-feeding (Fig. 1d).
The rise in miR-122 level is expected, as it would help the cells to
restore CAT-1 levels back to normal. We verified that the
decrease in CAT-1 mRNA was not due to transcriptional
downregulation (Supplementary Fig. 1a). Interestingly, the effect
was specific for miR-122 alone, as levels of other miRNAs such as
let-7a, miR-16, miR-21, miR-24 and miR-125b were unaffected,
arguing against the possibility of a global increase in miRNA
levels on stress relief (Fig. 1c,e). The elevated miR-122 was
functionally active, as it was AGO2 associated. Consistent with
higher miR-122 level, CAT-1 mRNA also showed higher
association with AGO2 in re-fed cells (Supplementary Fig. 1b).
Transcriptional upregulation of miR-122 did not contribute to
the increased mature miR-122 level, as inhibition of RNA
Polymerase II by a-Amanitin could not prevent this increase
(Supplementary Fig. 1c). The increase in miR-122 was accom-
panied by a sharp decrease in pre-miR-122, suggesting increased
processing of pre-miR-122 to generate mature miR-122 on stress
reversal (Fig. 1f). As DICER1 processes pre-miRNA to the mature
form, we suspected a role of DICER1 in the miR-122 surge, but
did not detect any increase in DICER1 protein level on stress
reversal (Supplementary Fig. 2a). An increase in DICER1 activity
could potentially contribute to the observed increase in mature
miR-122. However, processing of other miRNAs was unchanged,
negating the possibility of global increase in DICER1 activity
(Fig. 1e). However, the increase in mature miR-122 on re-feeding
the starved cells was reduced on small interfering RNA (siRNA)-
mediated knockdown of DICER1, suggesting a requirement of
DICER1 in this process (Fig. 1g).
We hypothesized that CAT-1 along with all other stress-
induced elevated miR-122 target mRNAs trigger miR-122
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biogenesis on re-feeding of starved Huh7 cells. Therefore, if
stress-induced upregulation of these mRNAs is prevented, the
increase in mature miR-122 levels on stress relief should not
occur. To downregulate CAT-1 along with other miR-122 target
genes we introduced excess pre-miR-122 before starvation. Under
this condition, on relief of starvation, the target-driven miR-122
biogenesis was not observed compared with the control where a
nonspecific pre-miRNA was pre-expressed, confirming the role of
elevated miR-122 targets in promoting faster miR-122 maturation
(Supplementary Fig. 2c).
mRNAs increase the levels and activity of cognate miRNAs. To
validate whether target mRNA can trigger biogenesis of cognate
mature miRNA from their precursors, pre-miR-122 and reporter
target mRNAs were co-expressed in HEK293 cells that do not
express the liver-specific miR-122. This minimized any ambiguity
arising from transcriptional regulation of miR-122 expression in
the cell and provided a relatively clean system to study the effect
of target mRNA on miRNA levels. An increase in mature
miR-122 content was observed in the presence of target
mRNAs along with a decrease in the pre-miR-122 level in cells
transiently expressing pre-miR-122 along with target mRNA
bearing a single-bulged (RL-1 bulge-miR-122) or three-bulged
(RL-3 bulge-miR-122) miR-122-binding sites in their 30-UTRs
(Fig. 2a–c). Apart from miR-122, levels of other endogenous
miRNAs such as let-7a, miR-16 and miR-21 did not change
significantly in the presence of the miR-122 targets
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Figure 1 | Reversal of amino acid-starvation-induced stress increases miR-122 biogenesis in Huh7 cells. (a,b) Outline of the experimental set-up used
(a). Relative level of CAT-1 mRNA in Huh7 cells either fed or starved for 4 h and re-fed with media containing amino acids for another 2 h. CAT-1 mRNA
levels were quantified by quantitative reverse transcriptase-PCR with levels in Fed cells taken as 1 (b). (c) Effect of starvation and re-feeding on mature miR-
122 levels in Huh7 cells. Total RNA was extracted and 8mg RNA was used for northern blotting of mature miR-122, let-7a and miR-16. U6 snRNA was used
as loading control. (d) Copy number/number of molecules of mature miR-122 and CAT-1 mRNA per Huh7 cell calculated in fed, starved and re-fed Huh7
cells. Estimations were done by real-time-based methods. (e) Increase in mature miR-122 but not that of other non-relevant miRNAs, miR-16, miR-21, miR-
24 and miR-125b on relief of starvation. Real-time PCR-based quantification of mature miRNA levels in Huh7 cells starved for amino acids (4 h) and
subsequently re-fed (2 h). (f) Increase in mature miR-122 is accompanied by a concomitant decrease in pre-miR-122 on re-feeding the starved cells for 2 h.
Cellular small RNA population was isolated by mirVANA kit to minimize possible contamination of pri-miR-122 and real-time-based assays were carried out
to quantify pre-miR-122. Pre-miR-122 detected by northern blotting with 15 mg total RNA. Synthetic pre-miR-122 was used as a size marker to determine the
position of the pre-miR-122 in the northern blotting. (g) Increase of mature miR-122 on re-feeding of starved cells is reduced in DICER1 knockdown Huh7
cells. miR-16 and miR-21 did not show any significant change. siDICER1-mediated knockdown of DICER1 is confirmed by western blotting. Paired two-tailed
Student’s t-tests were used for all comparisons. *Po0.05, **Po0.01 and ***Po0.001. Error bars represent s.d. (nZ3).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12200 ARTICLE
NATURE COMMUNICATIONS | 7:12200 |DOI: 10.1038/ncomms12200 |www.nature.com/naturecommunications 3
(Supplementary Fig. 3a). The level of another miRNA, let-7a, also
increased specifically on expression of its target mRNA bearing
three-bulged let-7a sites (RL-3 bulge-let-7a) (Supplementary
Fig. 3b). It has been shown that the 50-half of siRNA is essential
for target RNA recognition, whereas the 30-half contributes to the
stability of the association2. It was observed that the 50-seed
sequence is crucial for target recognition as a seed sequence
mutant RL-3 bulge-miR-122 (W50) is not repressible by
miR-122 (Supplementary Fig. 3d). Interestingly, the 30-half also
binds target mRNA (Supplementary Fig. 3c) and the 30-sequence
mutant RL-3 bulge-miR-122 (W30) was less efficiently
repressed than the wild-type mRNA (Supplementary Fig. 3d).
Altering the 50-seed-binding sequences on the target mRNA
significantly down regulate the target-driven miRNA increase.
Tampering with the 30-half sequence also affected target-driven
biogenesis, indicating that both halves contribute to the process
(Fig. 2d).
Are these enhanced miRNAs functionally active? In vitro RISC
cleavage assay with equivalent amounts of affinity-purified AGO2
demonstrated increased miRISC activity in the presence of
RL-3 bulge-miR-122 (Fig. 2e). Further quantification of miR-
122 association with affinity-purified AGOs revealed an elevated
association of mature miR-122 with all the three Argonautes
tested, in a target-dependent manner (Supplementary Fig. 3e).
Furthermore, the in vivo repressive activity of miR-122 was
enhanced in the presence of its target GFP-3 bulge-miR-122
compared with green fluorescent protein (GFP) control. The
effect of target mRNA was specific, as let-7a target mRNA
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Figure 2 | Target mRNA-dependent increase of mature miR-122 in human cells. (a) Scheme of the different target mRNAs used. Positions of the
miR-122-binding sites are indicated. (b) Effect of RL-3 bulge-miR-122 on mature miR-122 level in cells transfected with pre-miR-122 and reporter plasmids
or in vitro-transcribed mRNAs. In experiment described in the right panel, HEK293 cells co-transfected with plasmid encoding pre-miR-122 (pmiR-122) and
RL reporters were used. Total RNA was extracted and northern blotted for mature miR-122, for all the experiments. U6 snRNA was used as loading control.
(c) Mature miR-122, pre-miR-122 and target mRNA levels were quantified by quantitative reverse transcriptase–PCR in HEK293 cells expressing target
mRNAs and co-transfected with plasmid encoding pre-miR-122. (d) Effect of modification of 50 or 30 miR-122-binding site on target mRNA-driven miRNA
elevation. Relative quantification of mature miR-122 level increase in the presence of target RL-3 bulge-miR-122 mRNA and in the presence of mRNAs
with weak 50- region (W50) or weak 30-region (W30). Relative levels were normalized against respective target mRNA levels. (e) In vitro RISC cleavage assay
done with protein equivalent amounts of affinity-purified FH-AGO2 isolated from pre-miR-122-transfected FH-AGO2 stable HEK293 cells expressing
RL-3 bulge-miR-122 or RL-con. @, Cleaved product of RISC assay; radio labeled 21-nt band serves as a marker. Paired two-tailed Student’s t-tests were
used for all comparisons. *Po0.05, **Po0.01 and ***Po0.001. Values plotted are means from at least three biological replicates for c and d, and two
biological replicates for e. Error bars represent s.d.
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increased let-7a repressive activity without affecting miR-122
activity in co-expressing cells (Supplementary Fig. 3f).
Target RNA concentration-dependent increase in miRNA level.
Expression of RL-1 bulge-miR-122 induced similar or slightly
higher mature miR-122 levels in comparison with RL-3 bulge-
miR-122, despite having a single miR-122-binding site. This was
due to higher abundance of RL-1 bulge-miR-122 mRNA
compared with RL-3 bulge-miR-122 (Fig. 2c). However, the
amount of mature miR-122 formed per unit of mRNA was higher
for the mRNA with three miRNA-binding sites than with only a
single binding site (Fig. 3a). Therefore, the concentration of free
miRNA binding sites either placed in cis (RL-3 bulge-miR-122)
or in trans (RL-1 bulge-miR-122) regulate target-dependent
miRNA biogenesis. To test the effect of target mRNA con-
centration on the observed miRNA increase, we introduced
increasing amounts of synthetic target mRNAs and observed a
correlative increase in mature miR-122 levels coupled with a
simultaneous reduction in pre-miR122 levels (Fig. 3b). These
show that the target-dependent miRNA increase is a function of
the concentration of target mRNA. This implies that agents that
increase target mRNA levels can promote higher miRNA bio-
genesis. Cycloheximide, a translation elongation blocker, when
applied at a low concentration of 100 ngml 1 diminished trans-
lation efficiency26 (Supplementary Fig. 4a,b). Cycloheximide-
mediated reduced translation led to higher reporter mRNA levels
and a corresponding increase in mature miR-122 (Supplementary
Fig. 4c).
To investigate how the translatability of the target mRNA may
affect substrate-dependent miRNA increase we manipulated the
mRNA in various ways so as to alter its translation efficiency.
Introduction of a cis-regulatory p27 structural element, in the
50-UTR of RL-3 bulge-let-7a reduced mRNA translation
efficiency by impaired translation initiation27,28 (Supplementary
Fig. 4d,e). This was accompanied by an increase in the
p27-containing target mRNA and increased let-7a levels in
HEK293 cells (Supplementary Fig. 4f). The presence of an iron
response element (IRE) in 50-UTR of mRNA regulates initiation
as a function of intracellular Fe2þ concentration. The binding of
iron regulatory protein (IRP) to the IRE sequence inhibits its
translation by preventing 40S binding to mRNA29,30. Under low
Fe2þ conditions, IRP binds IRE and prevents translation
initiation, whereas high Fe2þ levels induce higher translation
initiation, owing to dissociation of IRP. Introduction of the
ferritin IRE in the 50-UTR of RL-3 bulge-miR-122 is therefore
expected to regulate mRNA translation depending on cellular
iron availability (Fig. 3c). Impaired translation in the presence of
deferoxamine mesylate salt (DFMO; an iron chelator) was
confirmed by the relatively lower retention of the IRE-
containing mRNA in the polysomal fractions (Fig. 3d). Reduced
translation using DFMO as a Fe2þ chelator resulted in higher
mRNA levels and higher miR-122 formation (Fig. 3e). Thus,
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impaired translatability of the mRNA increased the target-driven
miRNA production, owing to their higher abundance.
mRNA increases biogenesis of mature miRNA from pre-miRNA.
Mechanistically, the target-driven increase in mature miRNA
level can stem from either enhanced stability of the existing
miRNA or increased biogenesis of the mature form from the
precursor. To test this, a doxycycline-inducible system was
developed to express pre-miR-122 in HEK293 cells already
expressing target mRNA. This would minimize the existence of
any preformed miRNP-122 and should serve as a useful tool to
monitor and measure de novo biogenesis of mature miRNA in the
presence of its target. There was a significant increase in the
de novo-synthesized mature miR-122 with time when RL-3
bulge-miR-122 was present. This was accompanied by a con-
comitant decrease in pre-miR-122 levels, indicating a higher rate
of mature miR-122 biogenesis from pre-miR-122 in presence of
RL-3 bulge-miR-122 (Fig. 4a). The decay kinetics of mature
miR-122 was similar in cells expressing RL-con and RL-3
bulge-miR-122, suggesting that the presence of target mRNA does
not have a stabilizing effect on miR-122 (Fig. 4b). To further
check the possible stabilizing effect of target mRNA, we incubated
preformed miRNP-122 with target mRNAs for up to 1 h in vitro.
The mature miR-122 content of miRISC was independent of the
presence of target mRNA, arguing against the stabilizing action of
target mRNA (Fig. 4c).
Target mRNA enhances the activity of AGO2-associated DICER1.
To verify whether target mRNA induces higher miRNA bio-
genesis by faster pre-miRNA processing, we performed an in vitro
RISC-loading assay with immunoisolated AGO2, synthetic pre-
miR-122 and in vitro transcribed m7G-capped and poly(A)-tailed
target mRNAs. The presence of target mRNA enhanced the
pre-miRNA processing activity, leading to higher accumulation
of mature miR-122 with AGO2 (Fig. 5a). The increased
accumulation of mature/5p strand within AGO2 in the presence
of miR-122 targets was accompanied by a corresponding decrease
in AGO2-bound passenger/3p strand, indicative of successful
RISC activation (Fig. 5b)31. Higher biogenesis of let-7a in the
presence of its target RL-3 bulge-let-7a was also observed,
confirming the generality of target-driven miRNA biogenesis
(Fig. 5c). In the in vitro pre-miRNA-processing assays with target
mRNAs W50 and W30, we observed lower target-driven miR-122
biogenesis for W30 and W50 target RNA (Supplementary Fig. 5a).
During mammalian miRNP assembly by the miRLC, DICER1
processes a pre-miRNA and loads the mature form into a
RL-3xbulge-miR-122
14 h 14 h24 h 24 h
Mature
miR-122
pre-
miR-122
R
el
at
iv
e 
am
ou
nt
DOX
14 h
24 h
Time (h)
48 h
24 h
48 h
72 h
Time (min)
0 20 40 60 80
0 20 40 60 80 0 20 40 60 80
R
el
at
iv
e 
st
ab
ilit
y 
of
m
a
tu
re
 m
iR
-1
22
 in
 v
itr
o
Preformed
miRISC 122
37 °C for 10,
20, 30, 60 min
3
2
1
0
Time (h)
R
el
at
iv
e 
am
ou
nt
 o
f  
m
RN
A
In vitro RISC cleavage
assay to determine
the amount of miR-122
retained in AGO2
Expressing RL-con/RL3x-bulge-
miR-122 with inducible miR-122
Tet-ON stable
HEK293 cells
2.0
1.5
1.0
0.5
0.0
1.5
1.0
0.5
0.0
1.5
1.0
0.5
0.0
ns ns
*
***
M
at
ur
e 
an
d 
pr
ec
ur
so
r
m
iR
-1
22
 q
ua
nt
ifie
d
RL-con In vitro transcribed
mRNA
RL-3xbulge-
miR-122
RL-con
HEK293 cells
expressing limiting
amounts of 
miR-122
Transfected with RL-
con/RL-3x-bulge-miR-122
M
at
ur
e 
m
iR
-1
22
qu
an
tif
ie
d
RL-con
RL-3xbulge-
miR-122
R
el
at
iv
e 
am
ou
nt
 o
f
m
a
tu
re
 m
iR
-1
22
RL-con
RL-3xbulge
-miR-122
a c
b
Figure 4 | Target mRNA drives increased biogenesis of mature miRNA from pre-miRNA. (a) De novo synthesis of mature miR-122 in the presence of
target mRNA is accompanied by a simultaneous drop in pre-miR-122 level. Experimental format is illustrated in the left panel. Tet-ON HEK293 cells were
induced for specific time points with doxycycline to synthesize pre-miR-122 from a plasmid with Tet-response element. Cells were harvested after 14 and
24h, and mature and pre-miR-122 levels quantified. To measure the relative changes at 24 h, values at 14 h are taken as the unit. (b) Target mRNA-induced
increase of miRNA levels does not occur due to enhanced stability of a preformed miRNP in the presence of target mRNA. Cells were transfected with 1 mM
synthetic pre-miR-122. After 48 h, cells were again transfected with RL-con or RL-3 bulge-miR-122 plasmids. This was followed by RNA isolation after 24,
48 and 72 h, and mature miR-122 levels quantified to plot the decay rate of mature miR-122. Relative changes in levels of target RNAs over time have been
plotted. (c) FH-AGO2 was immunoprecipitated from FH-AGO2-stable HEK293 cells transfected with pre-miR-122 plasmid and FH-AGO2 beads
corresponding toB2 106 cells were incubated with 500ng in vitro-transcribed RL-con or RL-3 bulge-miR-122 mRNA in a 20 ml reaction for increasing
time. The supernatant was removed and on-bead RISC cleavage assay was subsequently performed to quantify the amount of miR-122 retained with AGO2
post interaction with target mRNA. Paired two-tailed Student’s t-tests were used for all comparisons. *Po0.05, **Po0.01 and ***Po0.001. Values plotted
are means from at least three biological replicates for a and two for b and c. Error bars represent s.d.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12200
6 NATURE COMMUNICATIONS | 7:12200 | DOI: 10.1038/ncomms12200 |www.nature.com/naturecommunications
miRNA-free Argonaute16. Therefore, it is reasonable that
increased activity of AGO-associated DICER1 within the
miRLC contributes to the observed increase in miRNA
maturation. The role of AGO2-associated DICER1 was
confirmed by the observations that knockdown of DICER1
by siRNA (Supplementary Fig. 6) or DICER1 cleavage by soluble
Leishmanial antigen (SLA)32, containing the metalopretease gp63
that specifically cleave DICER1, resulted in significant reduction
of target-driven miRNA biogenesis (Fig. 5d).
To validate the contribution of AGO2-associated DICER1 in
target-dependent processing of pre-miRNAs we reconstituted the
human RISC loading machinery in vitro using recombinant
AGO2 (rAGO2) with catalytic amounts of recombinant DICER1
(rDICER1). rDICER1 could process the pre-miR-122 in vitro but
rAGO2 alone failed to process pre-miR-122, eliminating the
possibility of enhanced miRNA maturation by increased AGO2
slicer activity33 (Supplementary Fig. 5b,c). In assays using
rDICER1 and rAGO2, target-dependent biogenesis of miR-122
was observed. However, heat denaturation of rAGO2 impaired
the target-driven increase, confirming the importance of AGO2
association of DICER1 in the observed increase in miR-122
biogenesis (Fig. 6a).
It is difficult to envisage how a miRNA-binding site on the
mRNA triggers enhanced activity of DICER1 associated with
AGO2. DICER1 acts as a multiple-turnover enzyme in the
miRLC, wherein it catalyses one cycle of miRNA loading on to
associated AGO2, then switches to another free AGO2 molecule
to catalyse another cycle of loading16. As catalytic activity of
DICER1 is directly coupled to AGO2 loading of miRNA,
increased DICER1 activity in the presence of target mRNA
implies increased AGO2 loading. We hypothesize that
immediately after a successful miRNA loading, DICER1
remains associated with AGO2. The complex associates with a
mRNA and scans for a target site2. Once the target site is found
and a stable hybrid is formed, DICER1 dissociates from the
miRLC and jumps to a fresh Argonaute for another round of
miRNA loading. This step is accelerated when a target mRNA is
abundant, thereby contributing to increased processivity of
DICER1, which leads to loading of a greater number of
Argonaute molecules per unit of time. In support of this model,
it was observed that with increasing amounts of rAGO2 and a
constant amount of rDICER1, there was a concentration-
dependent increase in mature let-7a formation in the presence
of RL-3 bulge-let-7a but not RL-con in an in vitro assay
(Fig. 6b). Furthermore, it was observed that blocking the mRNA
scanning process of loaded AGO2 by introducing a five BoxB
hairpin RNA secondary structural element in the 30-UTR reduces
the rate for target site finding and affected target-driven miRNA
biogenesis (Fig. 6c and Supplementary Fig. 5d).
We further attempted to verify the importance of increased
DICER1 processivity on miRNA processing and loading in an
in vitro system. According to the proposed model, after scanning
along the 30-UTR, binding of miRISC with the target site should
trigger dissociation of AGO2-associated DICER1. Hence, the
amount of DICER1 associated with target site (via-AGO2) should
be lower compared with its association with the other half of the
30-UTR. To test this we immunoprecipitated DICER1 and AGO2
after completion of the in vitro processing reaction and analysed
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the 30-UTR regions that they were directly or indirectly associated
with. DICER1 showed relatively less association with the region
proximal to target site compared with AGO2, which showed
association both with regions distal as well as proximal to miRNA
target site regions (Fig. 6d). The processivity of AGO2-dissociated
DICER1 during the target-driven miRNA biogenesis was
measured by adding a foreign pre-miRNA molecule in the
system and scoring its biogenesis. We introduced pre-miR-122 as
the precursor of non-relevant miRNA in the in vitro assay where
RL-con or RL-3 bulge-let-7a was incubated with let-7a miRISC.
It was observed that the amount of mature miR-122 formed was
higher in the presence of the let-7a target mRNA compared with
that of RL-con (Fig. 6e).
Discussion
We have documented that target mRNA triggers increased
miRNA production and activity in HEK293 cells. As it is
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difficult to identify the exact reason for the observed increase in
miRNA activity in cellular context, we wanted to recapitulate
the observation in vitro. Evidences from in vitro studies suggested
that increase in DICER1-mediated pre-miRNA processing is
responsible for the target-driven increase in miRNA biogenesis.
Notably, the target mRNA-induced miRNAs are loaded into
AGO proteins to form active miRNPs.
Gregory et al.15 have shown a ‘physical and functional
coupling’ between pre-miRNA processing by DICER1 and
loading of AGO2 to assemble a functional RISC. They observed
that target RNA cleavage is ten times more efficient when pre-
miRNA, a DICER1 substrate, is used compared with a miRNA
duplex. As DICER1 catalytic activity is directly coupled to RISC
loading, the target mRNA-induced increase in DICER1 activity
that we observe here leads to increased AGO loading. The role of
DICER1 as a multiple turnover enzyme during RISC loading is
established. Our work proposes that the miRLC does not
dissociate immediately after AGO2 has been loaded. Instead, it
scans the mRNA and once a target site is found and stable
miRNP binding occurs, DICER1 dissociates and catalyses another
cycle of miRNA loading. As DICER1-mediated AGO loading is
processive, the processivity of the enzyme is enhanced when
target mRNA is abundant, contributing to higher number of
successful loading cycles per unit time (Fig. 7).
The exact mechanism of miRNA passenger strand removal
during AGO2 loading has not been resolved. Apart from the
slicer-dependent mechanism of miRNA* strand cleavage31,34,
a slicer-independent mechanism has been recognized that plays
a more prominent role in loading of miRNAs in mammalian
AGOs35. Our model supports the second mechanism whereby
both the sense and anti-sense strand may remain associated with
AGO2 post loading; in case of increased local abundance of target
sites, the sense strand hybridizes to target sites and therefore the
removal of passenger strand is more efficient (Fig. 5b). In fact,
it has been proposed in a recent report that in siRNA-mediated
RNA interference, product release from AGO2 is accelerated in
the presence of excess target RNA36; this can be accounted for by
target RNA-dependent enhancement of RISC activity.
Turnover of miRNAs helps the cell to maintain a steady-state
level of miRNPs. In certain cell types such as neurons, where
dynamic changes in gene expression occur, 30-tailing of miRNAs
with non-templated nucleotides, 30–50 trimming and rapid
miRNA degradation have been reported37. Trimming and
tailing have also been reported in Drosophila22. Interestingly,
this degradation was shown to be induced by highly
complementary target mRNAs. Several other articles have also
reported miRNA degradation induced by highly complementary
targets, a phenomenon referred to as target RNA-directed miRNA
degradation (TDMD)37–39. Apparently, our observations seem to
contradict these findings. However, it should be noted that where
TDMD refers to turnover of preformed mature miRNAs by
complementary target mRNAs, we report increased de novo
biogenesis of miRNPs by target mRNAs. In the cellular context,
one phenomenon can be masked by the other and due to
unavailability of any inhibitor of TDMD it is difficult to factually
distinguish between the two processes. Therefore, we resorted to an
in vitro set-up with recombinant proteins and synthetic RNAs, to
nullify any cellular event that might complicate our observation.
Contrary to TDMD, Chatterjee et al., reported that complementary
target mRNAs prevent degradation of mature miRNAs in
C. elegans. Again, this process also depicts the fate of mature
preformed miRNAs being regulated by target mRNAs21.
We have provided evidence of target-driven miRNA biogenesis
using Huh7 hepatoma cells in which, on stress reversal, increased
levels of CAT-1 mRNA induced miR-122 production (Fig. 1).
Starved Huh7 cells harbour a huge repertoire of CAT-1 mRNA.
Hence, it is probable that CAT-1 can trigger increased miR-122
biogenesis in an attempt to restore cellular homeostasis on
reversal of stress induced by amino-acid starvation. However, as
CAT-1 is one of the numerous miR-122 target mRNAs that surge
in starved cells and is responsible for miR-122 increase in re-fed
cells, siRNA-mediated knockdown of CAT-1 could only partially
reduce the miR-122 level in re-fed cells (Supplementary Fig. 2b).
This acts as a feedback mechanism whereby a target mRNA can
autoregulate its own levels by driving synthesis of its cognate
miRNA. In fact, a miRNA autoregulatory circuit has been
reported to operate in C. elegans, whereby mature let-7 miRNP
binds and induces increased processing of let-7 primary
transcripts40. There can be a host of other such cellular
situations where such a mechanism can regulate miRNA
loading and consequently fine tune gene expression. During
miRNA biogenesis one strand of the precursor hairpin is selected
as the guide strand, whereas the other strand (miRNA*) is
degraded. This ‘strand bias’ theory has been formulated based on
the relative thermodynamic stability of the two sister strands
(5p and 3p) in the pre-miRNA; the strand with lesser stability is
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preferentially selected as guide, whereas the other strand is
degraded41. Examination of the thermodynamic stability profiles
of the pre-miRNA and mature miRNA revealed most of the
miRNAs are highly asymmetric with 5p as the guide strand, with
only a handful of miRNAs showing comparable stability of 5p
and 3p strands41,42. However, Ro et al.43 observed that selective
or simultaneous accumulation of both strands occur in a tissue-
specific manner. This implies that the two opposite strands can
target completely different sets of target mRNAs43. High-
throughput miRNA sequencing analysis has revealed that the
arm from which mature miRNA is generated can switch at
different developmental stages or in different tissues44. A study
showed that miR-142-5p was sequenced more frequently in the
ovary, testes and brain, and miR-142-3p was sequenced more
recurrently in embryonic and newborn samples17. Expression of
certain mRNAs is tissue specific or developmental stage specific.
Therefore, it is probable that the expression of a new mRNA at a
particular developmental stage will induce synthesis of cognate
miRNA (say 3p of a pre-miRNA); another mRNA in a
subsequent developmental stage can induce 5p of the same pre-
miRNA. Thus, target mRNA-driven miRNP biogenesis can act as
the molecular switch that can trigger selective expression of a
particular miRNA strand, thereby acting as a tool to configure
gene expression by directing miRNA arm switching.
The 30-UTR of most of the endogenous target mRNAs bear
binding sites for several miRNAs and one or more sites for a
single type of miRNA. Therefore, repression of a mRNA by a
miRNA can lead to biogenesis of a secondary miRNA that also
has a binding site on the same mRNA. This in turn will lead to
repression of a different mRNA that has sites for this secondary
miRNA. If both genes are members of the same cellular pathway,
then repression of one gene can influence expression of another
gene. This can act as a plausible mechanism of coordinating
gene expression by miRNAs, further supporting the role of these
small RNAs as ‘fine-tuners’ of gene expression. Importantly,
our findings reflect another layer of dynamicity in miRNAs
action, whereby cells can maintain only requisite levels of
specific miRNPs depending on target availability. Rather than
transcriptionally upregulating miRNA synthesis, modulating the
final step of biogenesis serves as an immediate means to sense
target RNA increase and subsequent enhancement of miRNA
production. This in turn helps the cell respond to specific and
urgent cellular needs.
Methods
Cell culture and transfections. Both Huh7 and HEK293 cells were obtained
from the laboratory of Witold Filipowicz. The cells were free of mycoplasma
contamination and were cultured in DMEM medium containing 2mM
L-glutamine and 10% heat-inactivated FCS as described earlier25,45,46. All
cell culture reagents were from Life Technologies. All plasmid transfections
were carried out with Lipofectamine 2000 and siRNAs with RNAiMax
(Life Technologies) using the manufacturer’s instructions.
In HEK293 cells, 1 mg target mRNA encoding plasmids were transfected in
six-well format with 5 pmol pre-miR-122 (Life Technologies) or 500 ng pre-miR-
122 encoding plasmid. Four hundred nanograms of synthetic in vitro-transcribed
target mRNAs were transfected in a 24-well format, unless described otherwise.
Transcription blockage was done with 10 mgml 1 a-Amanitin (Calbiochem).
For experiments using IRE constructs, 50 mM Hemin (Sigma) or 100 mM DFMO
(Calbiochem) was added to cell culture media for desired time. For experiments
using Tetracycline-inducible constructs, TET-ON HEK293 cells with the inducble
expression constructs were cultured in DMEM supplemented with 10%
TET-approved FCS (Clontech) and induction of expression of respective gene
product was carried out for indicated time durations using 300 ngml 1
Doxycycline (SIGMA)47.
siDICER1 were transfected at 30 nM concentration in a 24-well format and
siCAT-1 at 50 nM in the same format. CAT-1 siRNA (50-CCAGCCUUAUAGCU
GUUCU-30) was purchased from Eurogentec. Dharmacon SMARTpool ON-
TARGETplus siRNAs against DICER1 were purchased from Thermo Scientific. All
the plasmids used for the study have been listed in Supplementary Table 1.
Huh7 starvation and feeding. For starvation experiments, Huh7 cells grown in
normal DMEM were incubated in Hanks’ balanced salt solution (HBSS) supple-
mented with 10% dialysed FCS for 4 h followed by ‘re-feeding’ cells with HBSS
supplemented with 10% normal FCS for an additional 2 h. HBSS supplemented
with 10% normal FCS was used for ‘fed’ control.
Luciferase assay. Renilla luciferase (RL) and Firefly luciferase (FF) activities were
measured using a Dual-Luciferase Assay Kit (Promega), following the manu-
facturer’s instructions, on a VICTOR X3 Plate Reader with injectors (Perkin
Elmer). The ratio of Firefly luciferase normalized Renilla luciferase expression
levels for control is to reporter were used to calculate fold repression.
In the experiment using GFP target reporters, HEK293 cells were transfected in
a 24-well format with 250 ng pmiR-122, 100 ng firefly luciferase, 500 ng of GFP-con
or GFP-3 bulge-miR-122 along with 10 ng of luciferase reporter RL-con or
RL-3 bulge-miR-122, or RL-3 bulge-let-7a (additional control). After 24 h cells
were split and at 48 h luciferase activity measured. Firefly normalized RL values
were plotted. For GFP-3 bulge-let-7a reporter, exactly the same transfections
were performed with an exception of the GFP-3 bulge-miR-122 reporter.
RNA isolation and northern blotting. Total RNA was isolated using TRIzol
reagent (Life Technologies). Small RNA was isolated using mirVANA miRNA
isolation kit (Life Technologies) according to the manufacturer’s instructions.
Northern blotting of total cellular RNA (5–10 mg) was performed as described by
Pillai et al.48. In short, equal amount of total RNA was electrophoresed in 15%
Urea–PAGE followed by elecrtrophoretic transfer to nylon membrane. For
detection, g32P-labelled 22-nt miRCURY complementary LNA probes for miR-122
and let-7a (Exiqon) or complementary DNA probe for miR-16, U6 snRNA were
used. PhosphorImaging of the blots was performed in Cyclone Plus Storage
Phosphor System (Perkin Elmer). Uncropped versions of all blots are given in
Supplementary Fig. 7.
Real-time PCR. Real-time (reverse transcriptase) PCR for mRNA was done with
the Mesa Green qPCR Mastermix Plus for SYBR Assay-Low ROX (Eurogentec) by
using the 100–200 ng of the total RNA with the primers listed in Supplementary
Table 2. The endogenous control used was 18S ribosomal RNA. For the
quantification of miRNA, 30 ng of total RNA was taken. Following primers were
used for the amplifications of different miRNAs. For example, human let-7a (assay
ID 000377), human miR-122 (assay ID 000445), human miR-122* (assay ID
002130), human miR-16 (assay ID 000391), human miR-21 (assay ID 000397),
human miR-24 (assay ID 000402), human miR-125b (assay ID 000449), U6
snRNA (assay ID 001973) and Applied Biosystem Taqman chemistry-based
miRNA assay system were used for the experiment. All reactions were done in 7500
Applied Biosystem Real Time System or BIO-RAD CFX96 Real-Time system.
Cycles were set as per the manufacturer’s protocol.
Copy number determination. To determine copy number of miR-122, we
generated a standard curve using PAGE-purified synthetic miR-122. Five
nanograms of total RNA from HEK293 cells (does not contain miR-122) were
spiked with 106–1010 molecules of synthetic miR-122 and analysed by real-time
PCR using Taqman miRNA assays (Life Technologies). No Ct was obtained in a
control where synthetic miR-122 was not added. The Ct values obtained were
plotted to get the standard curve. Ct-values obtained from fed, starved or re-fed
samples using 5 and 25 ng of Huh7 RNA were converted to molecule copy number
using the standard curve. To calculate copy number of miR-122 per Huh7 cell, we
determined total amount of RNA obtained per Huh7 cell under fed, starved and
re-fed conditions by again generating a standard curve of total RNA versus number
of Huh7 cells. To do that, we counted cells using haemocytometer and isolated
RNA by TRIzol reagent and quantified total RNA using NanoDrop. The values
obtained were as follows: 34.69 pg (fed 4 h), 21.55 pg (starved 4 h) and 23.19 pg
(re-fed 2 h). This value was fairly consistent with Chang et al.24 who obtained 25 pg
of RNA per cell. The copy number obtained by our real-time-based method for
non-starved Huh7 (fed) was in that order of 104 (B1.2 104). This was lower than
that obtained by Siegrist et al.49, (3 104) using bead array technology.
Similarly, for CAT-1 mRNA standard curve was generated using 100 ng
RAW264.7 (mouse cell line) RNA spiked with 106–1010 molecules of in vitro-
transcribed RL-CatA mRNA that contains Renilla-coding region fused to the
30-UTR (bases 2,169–4,646) of human CAT-1 mRNA. A minus RL-catA control
yielded no amplification 30-UTR-specific primers were used and the same set of
primers were used to quantify CAT-1 from 500 ng RNA of Huh7 cells.
Immunoprecipitation. Immunoprecipitation of proteins was done essentially as
per published protocols25,50. Cells were lysed in a lysis buffer [20mM Tris-HCl pH
7.4, 200mM KCl, 5mM MgCl2, 1mM dithiothreitol (DTT), 1 EDTA-free
protease inhibitor (Roche), 5mM Vanadyl ribonucleoside comples (Sigma), 0.5%
Triton X-100, 0.5% sodium deoxycholate] at 4 C for 15min, followed by clearing
the lysate at 3,000 g for 10min. Protein G agarose beads (Invitrogen) were blocked
with 5% BSA in lysis buffer for 1 h and then incubated with required primary
antibody for another 3–4 h before the lyaste was added. A final dilution of 1:50
(antibody:lysate) was used for immunoprecipitation. Immunoprecipitation was
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carried out for 16 h at 4 C. Post washing with IP buffer (20mM Tris-HCl pH 7.4,
150mM KCl, 5mM MgCl2, 1mM DTT, 1 EDTA-free protease inhibitor
(Roche)), the beads were divided in two halves: one subjected to RNA isolation
with TRIzol LS and another for western blotting.
Immunoblotting. Western blotting of proteins was essentially performed as
described previously48. For immunoblotting, the cell lysates or immunoprecipitated
proteins were subjected to SDS–PAGE, transferred to nitrocellulose membrane and
probed with specific antibodies. Antibodies used were as follows: anti-AGO2
(Novus Biologicals; Cat# H00027161-M01; 1:1,000), anti-DICER (Bethyl; Cat#
A301-936A; 1:5,000), anti-HA (Roche; Cat# 11867431001; 1:1,000), b-Actin
(Sigma; Cat# A3854; 1:10,000) and phospho-eIF2a (Cell Signaling Technology;
Cat# 9721; 1:500). Imaging of all western blottings was done in UVP BioImager
600 system equipped with VisionWorks Life Science software (UVP) V6.80 and
quantification of bands done using the same software. Uncropped versions of all
blottings along with molecular-weight marker positions are included in
Supplementary Fig. 7.
Polysome isolation. Total polysome isolation was carried out as described51.
For total polysome isolation, around 6 106 HEK293 cells were lysed in a buffer
containing 10mM HEPES pH 8.0, 25mM KCl, 5mM MgCl2, 1mM DTT, 5mM
vanadyl ribonucleoside complex, 1% Triton X-100, 1% sodium deoxycholate and
1 EDTA-free protease inhibitor cocktail (Roche) supplemented with
Cycloheximide (100 mgml 1; Calbiochem). The lysate was cleared at 3,000 g for
10min followed by another round of pre-clearing at 20,000 g for 10min at 4 C.
The clarified lysate was loaded on a 30% sucrose cushion and ultracentrifuged at
100,000 g for 1 h at 4 C. The non-polysomal supernatant was collected from the
top. The sucrose cushion was washed with a buffer (10mM HEPES pH 8.0, 25mM
KCl, 5mM MgCl2, 1mM DTT), ultracentrifuged for additional 30min and the
polysomal pellet was finally resuspended in polysome buffer (10mM HEPES pH
8.0, 25mM KCl, 5mM MgCl2, 1mM DTT, 5mM vanadyl ribonucleoside complex,
1 EDTA-free protease inhibitor cocktail) for RNA isolation.
RISC cleavage assay. RISC cleavage assay was essentially performed as described
elsewhere with minor modifications50,51. HEK293 cells stably expressing
FH-AGO2 were transfected with pmiR-122 and target mRNA expression plasmids.
For miRISC isolation, cells were lysed, 48 h after transfection, in lysis buffer
[10mM HEPES pH 7.4, 200mM KCl, 5mM MgCl2, 1mM DTT, 1 EDTA-free
protease inhibitor (Roche), 5mM vanadyl ribonucleoside comples (Sigma), 1%
Triton X-100] at 4 C for 15min, followed by clearing the lysate at 3,000 g for
10min. The clarified supernatant was subjected to immunoprecipitation with
anti-FLAG M2 affinity gel (Sigma) for 16 h at 4 C. Beads were washed in IP buffer
[20mM Tris-HCl pH 7.4, 150mM KCl, 5mM MgCl2, 1mM DTT, 1 EDTA-free
protease inhibitor (Roche)] for three times at 4 C. The affinity-purified
miRISC was eluted from the beads using 3 FLAG Peptide (Sigma) as per the
manufacturer’s instructions in a RISC purification buffer (30mM HEPES pH 7.4,
100mM KCl, 5mM MgCl2, 0.5mM DTT, 3% glycerol).
Affinity-purified miRISC-122 were assayed for target RNA cleavage using a
36 nt RNA 50-AAAUUCAAACACCAUUGUCACACUCCACCAGAUUAA-30
bearing the sequence complementary to mature miR-122. Target RNA cleavage
assays were carried out in a total volume of 30 ml with 10 fmol of 5’ 32P-labelled
RNA in an assay buffer (100mM KCl, 5.75mM MgCl2, 2.5mM ATP, 0.5mM
GTP) and protein equivalent amounts of RISC at 30 C for 30min. RNA isolation
was carried out from the reaction mixture, cleaved products were analysed on a
12% denaturing 8M Urea–PAGE and visualized by autoradiography.
In vitro RISC loading assay. FH-AGO2 affinity purified on agarose beads
from FH-AGO2-stable HEK293 cells was incubated with 10 nM synthetic
50-phosphorylated pre-miR-122 or pre-let-7a, and 500 ng in vitro-transcribed target
mRNA in a 20-ml reaction in assay buffer [20mM Tris-HCl pH 7.5, 200mM KCl,
2mM MgCl2, 5% glycerol, 1mM DTT, 40U RNase inhibitor (Fermentas)] for 1 h
at 37 C followed by washing of the beads three times with IP buffer. Each reaction
was then divided into two halves: one for RNA isolation and the other for western
blotting of AGO2.
For assays with recombinant proteins, 50 ng of rAGO2 (Sino Biologicals) was
used with 0.1U of rDICER1 (Recombinant Human Dicer Enzyme kit, Genlantis)
keeping the rest of the reaction parameters same as above.
To measure the association of AGO2 and DICER1 along the 30-UTR,
FH-AGO2 stably expressing HEK293 cells was transfected with NHA-DICER1
transiently and FH-AGO2 immunoprecipitated with anti-FLAG agarose beads as
described before. FH-AGO2 was eluted from anti-FLAG beads with 3 FLAG
Peptide (Sigma) and isolated miRISC was incubated with RL-3 bulge-miR-122 at
37 C with 10 nM pre-miR-122 for 60min. The reaction was then divided in two
halves and immunoprecipitated with anti-AGO2 and anti-DICER1 antibodies for
3 h at 4 C. Beads were washed and RNA isolated using TRIzolLS followed by
quantitative reverse transcriptase–PCR using a single forward and two sets of
reverse primers.
For scoring DICER1 processivity, HEK293 cells transiently expressing
FH-AGO2 and pre-let-7a were lysed and FH-AGO2 immunoprecipitated as
described earlier. FH-AGO2 was eluted from anti-FLAG beads with 3
FLAG Peptide (Sigma) and isolated miRISC was incubated with RL-con or
RL-3 bulge-let-7a at 37 C with 10 nM pre-miR-122 for 30min. RNA was
isolated from the reaction and mature miR-122 formed quantified by real-time
PCR.
In vitro transcription. In vitro transcription was carried out using mMESSAGE
mMACHINE kit (Life Technologies) and poly A tailing of transcripts done with
Poly (A) tailing kit (Life Technologies) as per the manufacturer’s protocol. For
preparation of plasmid DNA template, RL-con, RL-1 bulge-miR-122, RL-3
bulge-miR-122, RL-3 bulge-miR-122 (W50), RL-3 bulge-miR-122 (W30) and
RL-CatA were digested for 4 h at 37 C with DraI (New England Biolabs) and
RL-3 bulge-let-7a was digested with HpaI (New England Biolabs); the rest of the
protocol was as per the manufacturer’s instructions. All transcripts obtained were
analysed and size verified by 6% Urea–PAGE and ethidium bromide-based
detection.
RNase protection assay. RNase Protection Assay was performed as described
earlier52. The synthetic miR-122 RNA probe was 50-end labelled with g32P ATP
using T4 Polynucleotide kinase (Ferementas) according to the manufacturer’s
protocol. Labelled miR-122 (1.5 pmol; 100 fmol radiolabelled and 1.4 pmol 50-end
labelled with cold ATP) was mixed with 500 fmol of target mRNA and precipitated
with 0.1 vol sodium acetate (pH 5.2) and 2.5 vol ice-cold ethanol for 1 h at  80 C.
The RNA recovered was dissolved in 30 ml Hybridization Buffer (40mM PIPES pH
6.8, 1mM EDTA pH 8.0, 0.4M NaCl, 80% deionized formamide), denatured at
85 C for 5min and then annealed at 35 C overnight. The mixture was next cooled
to room temperature and then RNase digestion was carried out in 300 ml of RNase
digestion mixture (300mM NaCl, 10mM Tris pH 7.4, 5mM EDTA pH 7.5, 30 mg
RNase A (Fermentas)) at 30 C 1 h. ProteinaseK treatment was done (10% SDS and
20mgml 1 Proteinase K (Roche) at 37 C for 30min) followed by RNA extraction
with acid phenol:chloroform pH 4.5 in the presence of 20 mg carrier transfer RNA
(Sigma). The samples were run in an 18% Urea–PAGE followed by drying the gel
and image was obtained using phosphorimager. For partial digestion, the reaction
was incubated on ice instead of 30 C.
Nuclear run-on transcription. Nuclear run-on transcription was performed as
described by Roberts et al.53. For isolation of intact nucleus from Huh7 cells,
B4 106 cells were lysed in NP-40 lysis buffer [10mM Tris-HCl pH 7.4, 10mM
NaCl, 3mM MgCl2 and 0.5% (vol/vol) NP-40]. Fractionation verified by western
blotting for nuclear and cytosolic markers. The nuclei were resuspended in 30 ml
Nuclei Storage Buffer [50mM Tris-HCl pH 8.3, 0.1mM EDTA, 5mM MgCl2, 40%
(vol/vol) glycerol] and subjected to run-on transcription in transcription buffer
(10mM Tris-HCl pH 8.3, 2.5mM MgCl2, 150mM KCl, 2mM DTT, 1mM ATP,
1mM CTP, 1mM GTP, 1mM GTP, 100U RNase inhibitor) at 30 C for 30min.
Immediately after the reaction, RNA was isolated using TRIzolLS and subjected to
DNaseI (New England Biolabs) treatment at 37 C for 15min. DNaseI was
inactivated by heating at 75 C for 5min. Six hundred nanograms of RNA was used
for cDNA preparation in a 10-ml reaction. Minus reverse transcriptase control was
done to verify the absence of any genomic DNA contamination.
SLA preparation. SLA was prepared using published protocol54. Briefly, for SLA
preparation, around 1010 Leishmania donovani cells were washed thrice with
1 PBS followed by five to six cycles of liquid nitrogen freeze thawing. The cells
were then sonicated in PBS with 0.04% NP-40 for six times. Lysate was cleared at
12,000 g for 10min at 4 C and the supernatant collected was SLA. Protein
estimation of SLA was done using Bradford method at 595 nm.
The in vitro DICER1 cleavage assay was carried out as mentioned elsewhere32.
Lysate of HEK293 cells stably expressing FH-AGO2 were prepared as for
immunoprecipitation. For each cleavage reaction, 30 mg cell lysate was incubated
with 20mg SLA in assay buffer (10mM Tris-HCl pH 7.5, 1mM DTT, 100mM KCl,
1 EDTA-free protease inhibitor (Roche)) and 1mgml 1 BSA for 30min at
37 C. This was followed by immunoprecipitation of the mixture with anti-FLAG
M2 agarose beads. Post immunoprecipitation, the beads were subjected to in vitro
DICER activity assay.
Statistical analysis. All graphs and statistical analyses were done in GraphPad
Prism 5.00 (GraphPad, San Diego, CA, USA). Nonparametric paired t-test were
used for analysis and P-values were determined. Error bars indicate mean±s.d.
Data availability. The authors declare that all data supporting the findings of this
study are available within the article and its Supplementary Information files or on
request.
References
1. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136,
215–233 (2009).
2. Ameres, S. L., Martinez, J. & Schroeder, R. Molecular basis for target RNA
recognition and cleavage by human RISC. Cell 130, 101–112 (2007).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12200 ARTICLE
NATURE COMMUNICATIONS | 7:12200 |DOI: 10.1038/ncomms12200 |www.nature.com/naturecommunications 11
3. Czech, B. & Hannon, G. J. Small RNA sorting: matchmaking for Argonautes.
Nat. Rev. Genet. 12, 19–31 (2011).
4. Sasaki, T., Shiohama, A., Minoshima, S. & Shimizu, N. Identification of eight
members of the Argonaute family in the human genome. Genomics 82,
323–330 (2003).
5. Wang, D. et al. Quantitative functions of Argonaute proteins in mammalian
development. Genes Dev. 26, 693–704 (2012).
6. Liu, J. et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science
305, 1437–1441 (2004).
7. Cai, X., Hagedorn, C. H. & Cullen, B. R. Human microRNAs are processed
from capped, polyadenylated transcripts that can also function as mRNAs.
RNA 10, 1957–1966 (2004).
8. Lee, Y. et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J.
23, 4051–4060 (2004).
9. Lee, Y., Jeon, K., Lee, J. T., Kim, S. & Kim, V. N. MicroRNA maturation:
stepwise processing and subcellular localization. EMBO J. 21, 4663–4670
(2002).
10. Bohnsack, M. T., Czaplinski, K. & Gorlich, D. Exportin 5 is a
RanGTP-dependent dsRNA-binding protein that mediates nuclear
export of pre-miRNAs. RNA 10, 185–191 (2004).
11. Yi, R., Qin, Y., Macara, I. G. & Cullen, B. R. Exportin-5 mediates the nuclear
export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17, 3011–3016
(2003).
12. Lund, E., Guttinger, S., Calado, A., Dahlberg, J. E. & Kutay, U. Nuclear export
of microRNA precursors. Science 303, 95–98 (2004).
13. Hutvagner, G. et al. A cellular function for the RNA-interference enzyme
Dicer in the maturation of the let-7 small temporal RNA. Science 293, 834–838
(2001).
14. Bernstein, E., Caudy, A. A., Hammond, S. M. & Hannon, G. J. Role for a
bidentate ribonuclease in the initiation step of RNA interference. Nature 409,
363–366 (2001).
15. Gregory, R. I., Chendrimada, T. P., Cooch, N. & Shiekhattar, R. Human RISC
couples microRNA biogenesis and posttranscriptional gene silencing. Cell 123,
631–640 (2005).
16. Maniataki, E. & Mourelatos, Z. A human, ATP-independent, RISC assembly
machine fueled by pre-miRNA. Genes Dev. 19, 2979–2990 (2005).
17. Ha, M. & Kim, V. N. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell
Biol. 15, 509–524 (2014).
18. Zhang, H., Kolb, F. A., Jaskiewicz, L., Westhof, E. & Filipowicz, W. Single
processing center models for human Dicer and bacterial RNase III. Cell 118,
57–68 (2004).
19. Tahbaz, N. et al. Characterization of the interactions between mammalian PAZ
PIWI domain proteins and Dicer. EMBO Rep. 5, 189–194 (2004).
20. Haase, A. D. et al. TRBP, a regulator of cellular PKR and HIV-1 virus
expression, interacts with Dicer and functions in RNA silencing. EMBO Rep. 6,
961–967 (2005).
21. Chatterjee, S. & Grosshans, H. Active turnover modulates mature microRNA
activity in Caenorhabditis elegans. Nature 461, 546–549 (2009).
22. Ameres, S. L. et al. Target RNA-directed trimming and tailing of small silencing
RNAs. Science 328, 1534–1539 (2010).
23. Hatzoglou, M., Fernandez, J., Yaman, I. & Closs, E. Regulation of cationic
amino acid transport: the story of the CAT-1 transporter. Annu. Rev. Nutr. 24,
377–399 (2004).
24. Chang, J. et al. miR-122, a mammalian liver-specific microRNA, is processed
from hcr mRNA and may downregulate the high affinity cationic amino acid
transporter CAT-1. RNA Biol. 1, 106–113 (2004).
25. Bhattacharyya, S. N., Habermacher, R., Martine, U., Closs, E. I. &
Filipowicz, W. Relief of microRNA-mediated translational repression in
human cells subjected to stress. Cell 125, 1111–1124 (2006).
26. Kong, Y. W. et al. The mechanism of micro-RNA-mediated translation
repression is determined by the promoter of the target gene. Proc. Natl Acad.
Sci. USA 105, 8866–8871 (2008).
27. Coleman, J. & Miskimins, W. K. Structure and activity of the internal ribosome
entry site within the human p27 Kip1 50-untranslated region. RNA Biol. 6,
84–89 (2009).
28. Millard, S. S., Vidal, A., Markus, M. & Koff, A. A U-rich element in the 50
untranslated region is necessary for the translation of p27 mRNA. Mol. Cell
Biol. 20, 5947–5959 (2000).
29. Hentze, M. W. et al. A cis-acting element is necessary and sufficient for
translational regulation of human ferritin expression in response to iron. Proc.
Natl Acad. Sci. USA 84, 6730–6734 (1987).
30. Theil, E. C. Iron regulatory elements (IREs): a family of mRNA non-coding
sequences. Biochem. J. 304, 1–11 (1994).
31. Matranga, C., Tomari, Y., Shin, C., Bartel, D. P. & Zamore, P. D. Passenger-
strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi
enzyme complexes. Cell 123, 607–620 (2005).
32. Ghosh, J., Bose, M., Roy, S. & Bhattacharyya, S. N. Leishmania donovani targets
Dicer1 to downregulate miR-122, lower serum cholesterol, and facilitate murine
liver infection. Cell Host Microbe 13, 277–288 (2013).
33. Diederichs, S. & Haber, D. A. et al. Dual role for argonautes in microRNA
processing and posttranscriptional regulation of microRNA expression. Cell
131, 1097–1108 (2007).
34. Leuschner, P. J., Ameres, S. L., Kueng, S. & Martinez, J. Cleavage of the siRNA
passenger strand during RISC assembly in human cells. EMBO reports 7, 314–
320 (2006).
35. Park, J. H.. & Shin, C. Slicer-independent mechanism drives small-RNA strand
separation during human RISC assembly. Nucleic Acids Res 43, 9418–9433
(2015).
36. Dornseifer, S. et al. RNAi revised - target mRNA-dependent enhancement of
gene silencing. Nucleic Acids Res 43, 10623–10632 (2015).
37. de la Mata, M. et al. Potent degradation of neuronal miRNAs induced by highly
complementary targets. EMBO Rep. 16, 500–511 (2015).
38. Cazalla, D., Yario, T. & Steitz, J. A. Down-regulation of a host microRNA by a
Herpesvirus saimiri noncoding RNA. Science 328, 1563–1566 (2010).
39. Krol, J. et al. Characterizing light-regulated retinal microRNAs reveals rapid
turnover as a common property of neuronal microRNAs. Cell 141, 618–631
(2010).
40. Zisoulis, D. G., Kai, Z. S., Chang, R. K. & Pasquinelli, A. E. Autoregulation of
microRNA biogenesis by let-7 and Argonaute. Nature 486, 541–544 (2012).
41. Khvorova, A., Reynolds, A. & Jayasena, S. D. Functional siRNAs and miRNAs
exhibit strand bias. Cell 115, 209–216 (2003).
42. Schwarz, D. S. et al. Asymmetry in the assembly of the RNAi enzyme complex.
Cell 115, 199–208 (2003).
43. Ro, S., Park, C., Young, D., Sanders, K. M. & Yan, W. Tissue-dependent paired
expression of miRNAs. Nucleic Acids Res. 35, 5944–5953 (2007).
44. Griffiths-Jones, S., Hui, J. H., Marco, A. & Ronshaugen, M. MicroRNA
evolution by arm switching. EMBO Rep. 12, 172–177 (2011).
45. Loedige, I., Gaidatzis, D., Sack, R., Meister, G. & Filipowicz, W. The
mammalian TRIM-NHL protein TRIM71/LIN-41 is a repressor of mRNA
function. Nucleic Acids Res 41, 518–532 (2013).
46. Schmitter, D. et al. Effects of Dicer and Argonaute down-regulation on mRNA
levels in human HEK293 cells. Nucleic Acids Res 34, 4801–4815 (2006).
47. Barman, B. & Bhattacharyya, S. N. mRNA Targeting to Endoplasmic Reticulum
Precedes Ago Protein Interaction and MicroRNA (miRNA)-mediated
Translation Repression in Mammalian Cells. J Biol Chem 290, 24650–24656
(2015).
48. Pillai, R. S. et al. Inhibition of translational initiation by Let-7 MicroRNA in
human cells. Science 309, 1573–1576 (2005).
49. Siegrist, F., Singer, T. & Certa, U. MicroRNA Expression Profiling by Bead
Array Technology in Human Tumor Cell Lines Treated with Interferon-Alpha-
2a. Biol Proced Online 11, 113–129 (2009).
50. Kundu, P., Fabian, M. R., Sonenberg, N., Bhattacharyya, S. N. & Filipowicz, W.
HuR protein attenuates miRNA-mediated repression by promoting miRISC
dissociation from the target RNA. Nucleic acids research 40, 5088–100 (2012).
51. Mazumder, A., Bose, M., Chakraborty, A., Chakrabarti, S. & Bhattacharyya, S.
N. A transient reversal of miRNA-mediated repression controls macrophage
activation. EMBO Rep 14, 1008–1016 (2013).
52. Azrolan, N. & Breslow, J. L. A solution hybridization/RNase protection assay
with riboprobes to determine absolute levels of apoB, A-I, and E mRNA in
human hepatoma cell lines. J Lipid Res 31, 1141–1146 (1990).
53. Roberts, T. C. et al. Quantification of nascent transcription by bromouridine
immunocapture nuclear run-on RT-qPCR. Nat Protoc 10, 1198–1211 (2015).
54. De, T. & Roy, S. Infectivity and attenuation of Leishmania donovani
promastigotes: association of galactosyl transferase with loss of parasite
virulence. J. Parasitol. 85, 54–59 (1999).
Acknowledgements
We are thankful to Witold Filipowicz for majority of the constructs used in this study.
We also thank Ramesh Pillai for critical comments and Samit Adhya for critical reading
of the manuscript. We thank all members of RBRL for their help and cooperation. We
also thank the funding bodies, the Wellcome Trust, London (084324/Z/07/A) and CSIR-
intramural support system. M.B. receives his SPM fellowship from CSIR, whereas S.N.B.
was supported by Wellcome Trust ISRF.
Author contributions
M.B. performed all experiments and wrote the manuscript. S.N.B. conceived the
experiments, analysed the data and wrote the manuscript.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12200
12 NATURE COMMUNICATIONS | 7:12200 | DOI: 10.1038/ncomms12200 |www.nature.com/naturecommunications
Competing interests statement The authors declare no conflict of interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Bose, M. and Bhattacharyya, S. N. Target-dependent
biogenesis of cognate microRNAs in human cells. Nat. Commun. 7:12200
doi: 10.1038/ncomms12200 (2016).
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
r The Author(s) 2016
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12200 ARTICLE
NATURE COMMUNICATIONS | 7:12200 |DOI: 10.1038/ncomms12200 |www.nature.com/naturecommunications 13
